Displaying drugs 12401 - 12425 of 15131 in total
Triacetylchitotriose
Experimental
1-Deaza-Adenosine
Experimental
Tretazicar
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
Investigational
Matched Description: … Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety …
Fructose -6-Phosphate
Experimental
2-deoxy-2-fluoro-α-D-glucose
Experimental
beta-D-Ribopyranose
Experimental
2-[(Dioxidophosphoranyl)oxy]benzoate
Experimental
Trencam-3,2-Hopo
Experimental
4-Phospho-D-erythronohydroxamic acid
Experimental
2-Deoxy-Glucitol-6-Phosphate
Experimental
L-Glycero-D-Manno-Heptopyranose
Experimental
Allosamidin
Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and can be utilized as potent antifungal agent.
Experimental
Matched Description: … inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and …
Human blood group H type 1 trisaccharide
Experimental
1,6-DI-O-PHOSPHONO-D-MANNITOL
Experimental
Neamine
Experimental
Tetomilast
Tetomilast has been used in trials studying the treatment of Crohn Disease, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease.
Investigational
Matched Description: … Tetomilast has been used in trials studying the treatment of Crohn Disease, Colitis, Ulcerative, and …
Tezosentan
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
Investigational
Displaying drugs 12401 - 12425 of 15131 in total